Nicotinamide Riboside Supplement for MDS
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial tests whether a supplement called nicotinamide riboside can help people with a blood disorder called MDS (myelodysplastic syndrome) or early warning signs of it. The supplement is meant to support your bone marrow's ability to make healthy blood cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have MDS (lower-risk type) or high-risk early warning signs (CCUS)
- You must be 18 years or older and able to follow all study procedures
- Your kidneys must work adequately (creatinine clearance ≥ 30 mL/min)
- Your liver function must be adequate (specific liver enzyme levels within limits)
- You cannot eat grapefruit, Seville oranges, or star fruit during the study
- You must not be pregnant, planning pregnancy, or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a supplement called nicotinamide riboside (NR) can help people with rare forms of parkinsonism (PSP, MSA, or CBS). It is a double-blind study, meaning neither you nor the doctors will know if you are getting the real supplement or a placebo.
This trial studies whether a supplement called nicotinamide riboside (a vitamin-like product) can be given safely during allogeneic bone marrow transplant. It may help researchers understand how well it works and how it affects recovery for people getting a donor transplant.
This Phase 2 trial studies whether a vitamin-like supplement called nicotinamide riboside can slow or improve disability in progressive multiple sclerosis. It may help people whose symptoms have been steadily getting worse over the last 2 years.
This trial tests a nutritional supplement (nicotinamide riboside) to see how it affects blood flow in healthy adults. It may help understand how to support vascular health as we age.
This trial tests whether a supplement called NMN is safe and well-tolerated in children and adults with a rare genetic condition called DHDDS-CDG. NMN may help support cellular energy and protein production, which are affected by this condition.
This trial tests an experimental drug, HS-20106, to see if it can improve low red blood cell counts (anemia) for people with a certain type of bone marrow disorder called myelodysplastic syndromes (MDS), which is not high risk. It might be an option if you have not received certain prior treatments.
Hear when a new Clonal Cytopenia of Undetermined Significance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.